Cooper/Haims Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $586K | Buy |
2,398
+60
| +3% | +$14K | 0.28% | 41 |
|
|
2025
Q4 | $484K | Hold |
2,338
| – | – | 0.22% | 46 |
|
|
2025
Q3 | $434K | Sell |
2,338
-42
| -2% | -$7.2K | 0.2% | 52 |
|
|
2025
Q2 | $364K | Buy |
2,380
+42
| +2% | +$6.46K | 0.18% | 50 |
|
|
2025
Q1 | $388K | Sell |
2,338
-44
| -2% | -$6.88K | 0.21% | 47 |
|
|
2024
Q4 | $345K | Hold |
2,382
| – | – | 0.2% | 52 |
|
|
2024
Q3 | $386K | Sell |
2,382
-431
| -15% | -$68.7K | 0.21% | 48 |
|
|
2024
Q2 | $411K | Sell |
2,813
-545
| -16% | -$81.1K | 0.23% | 44 |
|
|
2024
Q1 | $531K | Buy |
3,358
+201
| +6% | +$32K | 0.31% | 38 |
|
|
2023
Q4 | $495K | Sell |
3,157
-100
| -3% | -$15.3K | 0.28% | 33 |
|
|
2023
Q3 | $507K | Sell |
3,257
-3
| -0.1% | -$495 | 0.39% | 32 |
|
|
2023
Q2 | $540K | Buy |
3,260
+48
| +1% | +$7.75K | 0.41% | 31 |
|
|
2023
Q1 | $498K | Buy |
3,212
+7
| +0.2% | +$1.13K | 0.4% | 32 |
|
|
2022
Q4 | $566K | Sell |
3,205
-303
| -9% | -$52.3K | 0.4% | 32 |
|
|
2022
Q3 | $573K | Sell |
3,508
-98
| -3% | -$16.6K | 0.47% | 29 |
|
|
2022
Q2 | $640K | Sell |
3,606
-225
| -6% | -$40.1K | 0.42% | 27 |
|
|
2022
Q1 | $679K | Sell |
3,831
-42
| -1% | -$7.15K | 0.44% | 30 |
|
|
2021
Q4 | $663K | Sell |
3,873
-3,667
| -49% | -$600K | 0.41% | 33 |
|
|
2021
Q3 | $1.23M | Buy |
7,540
+3,883
| +106% | +$662K | 0.74% | 23 |
|
|
2021
Q2 | $602K | Buy |
3,657
+202
| +6% | +$33.4K | 0.4% | 31 |
|
|
2021
Q1 | $568K | Buy |
3,455
+36
| +1% | +$5.83K | 0.4% | 31 |
|
|
2020
Q4 | $538K | Buy |
3,419
+1
| +0% | +$148 | 0.41% | 27 |
|
|
2020
Q3 | $509K | Hold |
3,418
| – | – | 0.42% | 24 |
|
|
2020
Q2 | $481K | Buy |
3,418
+1
| +0% | +$146 | 0.39% | 26 |
|
|
2020
Q1 | $448K | Sell |
3,417
-51
| -1% | -$7.24K | 0.39% | 22 |
|
|
2019
Q4 | $506K | Buy |
3,468
+371
| +12% | +$50.3K | 0.28% | 24 |
|
|
2019
Q3 | $401K | Sell |
3,097
-3
| -0.1% | -$395 | 0.24% | 26 |
|
|
2019
Q2 | $432K | Sell |
3,100
-1,173
| -27% | -$162K | 0.27% | 22 |
|
|
2019
Q1 | $597K | Hold |
4,273
| – | – | 0.38% | 21 |
|
|
2018
Q4 | $551K | Buy |
4,273
+4
| +0.1% | +$558 | 0.38% | 20 |
|
|
2018
Q3 | $590K | Buy |
4,269
+86
| +2% | +$11.4K | 0.41% | 19 |
|
|
2018
Q2 | $508K | Buy |
4,183
+1,389
| +50% | +$173K | 0.38% | 20 |
|
|
2018
Q1 | $358K | Buy |
2,794
+52
| +2% | +$7.03K | 0.32% | 29 |
|
|
2017
Q4 | $383K | Buy |
+2,742
| New | +$382K | 0.35% | 25 |
|
Other funds holding JNJ
VCM
VPM
Cooper/Haims Advisors's JNJ Position: Q1 2026 in Review
Cooper/Haims Advisors increased its Johnson & Johnson (JNJ) stake by 2.6% in Q1 2026, buying an estimated $14K and bringing the position to 2,398 shares worth $586K. The position accounts for 0.28% of the portfolio, ranked #41.
Cooper/Haims Advisors first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.23M in Q3 2021. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Cooper/Haims Advisors held 2,398 shares of Johnson & Johnson worth $586K as of Q1 2026.
- Cooper/Haims Advisors bought 60 Johnson & Johnson shares in Q1 2026, an estimated $14K.
- Johnson & Johnson made up 0.28% of Cooper/Haims Advisors's portfolio in Q1 2026, its #41 holding.
- Cooper/Haims Advisors first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
- Cooper/Haims Advisors's Johnson & Johnson position peaked at $1.23M in Q3 2021.
- 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Cooper/Haims Advisors's 13F filing for Q1 2026, filed 12 May 2026.